Samsara Bio Capital, LLC Sutro Biopharma, Inc. Transaction History
Samsara Bio Capital, LLC
- $173 Million
- Q3 2024
A detailed history of Samsara Bio Capital, LLC transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Samsara Bio Capital, LLC holds 2,196,814 shares of STRO stock, worth $4.11 Million. This represents 4.41% of its overall portfolio holdings.
Number of Shares
2,196,814
Previous 2,196,814
-0.0%
Holding current value
$4.11 Million
Previous $6.44 Million
18.09%
% of portfolio
4.41%
Previous 3.31%
Shares
5 transactions
Others Institutions Holding STRO
# of Institutions
137Shares Held
62.4MCall Options Held
77.1KPut Options Held
31.4K-
Suvretta Capital Management, LLC New York, NY7.19MShares$13.4 Million0.98% of portfolio
-
Black Rock Inc. New York, NY6.91MShares$12.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.2MShares$7.84 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3MShares$5.61 Million0.03% of portfolio
-
Bio Impact Capital LLC Cambridge, MA2.83MShares$5.3 Million1.53% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $97.5M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...